September 27, 2025 a 01:01 pm

ELV: Fundamental Ratio Analysis - Elevance Health Inc.

An analysis of Elevance Health Inc. stock performance.

Elevance Health Inc., a leading health benefits company, is strategically positioning itself in the healthcare sector with a comprehensive portfolio of solutions. With robust operations catering to millions, its recent rebranding reflects an evolving identity. This analysis delves into its fundamental and historical performance metrics.

Fundamental Rating

Elevance Health Inc. boasts a stable performance with some areas of improvement, as reflected in the fundamental scores.

Category Score (1-5) Visualization
Discounted Cash Flow 5
Return On Equity 4
Return On Assets 4
Debt To Equity 1
Price To Earnings 2
Price To Book 3

Historical Rating

Analysis of historical scores provides insights into the trend and stability of the company’s performance.

Date Overall Score DCF ROE ROA Debt/Equity P/E P/B
2025-09-26 3 5 4 4 1 2 3
N/A 0 5 4 4 1 2 3

Analyst Price Targets

Analysts have set price targets highlighting potential growth, with a consensus leaning towards a "Buy" recommendation.

High Low Median Consensus
$500 $465 $482.5 $482.5
Elevance Health Inc. stock chart

Analyst Sentiment

The analyst sentiment gauge suggests a favorable outlook, reinforced by a notable count of "Buy" recommendations.

Recommendation Count Distribution
Strong Buy 0
Buy 28
Hold 9
Sell 0
Strong Sell 0

Conclusion

Elevance Health Inc. presents an overall stable performance with opportunities for improvement, particularly in reducing debt. The company's strong cash flow and equity returns are promising, and analysts maintain a positive outlook with a "Buy" consensus. Despite some volatility in debt ratios, its strategic initiatives underpin a robust growth narrative. Investors should weigh these dynamics against sector competitiveness.